Located in the Sinai Hospital of Baltimore BioIncubatorx, MD Diagnostics Inc develops molecular diagnostic tools for research, biopharmaceutical, and commercial clinical laboratory precision diagnostics markets. With diagnostic tools focused on cancer and other serious genetic diseases, the firm's primary technology is Expression Microdissection, which enables research and clinicians to isolate, procure and enrich specific cells/regions of interest from biopsies or other specimen samples. The effort is structured around developing a proof-of-concept for automating the pre- and post-operational steps of using the companys new system for extracting cells from human tissue for biopsies. xMDs system uses common antibodies and flashes of light to lift off cells of interest rather than traditional laser or razor-based extraction methods. The company plans to sell its system for applications in cancer and personalized or precision medicine.
